Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker
0 Comments
In calculating personal income tax, it’s important to understand the relationship between the terms adjusted gross income (AGI) and modified adjusted gross income (MAGI), as they can affect the amount of taxes that you owe. By subtracting certain deductions from your gross income, AGI can reduce the amount of your taxable income. MAGI, on the
0 Comments
In this article LCID MU SHW Micron Technology headquarters in Biose, Idaho, March 28, 2021. Jeremy Erickson | Bloomberg | Getty Images Check out the companies making headlines after the bell Tuesday: Sherwin-Williams — The paint company saw its stock fall 3% in extended trading after the company lowered its third-quarter sales guidance. “The persistent
0 Comments
Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more
0 Comments
Download Preston’s 1 page checklist for finding great stock picks: http://buffettsbooks.com/checklist Preston Pysh is the #1 selling Amazon author of two books on Warren Buffett. The books can be found at the following location: In this lesson, students learn about Net Income, Total Revenue, Cost of Revenue, and very basic valuation techniques.
0 Comments
Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and
0 Comments
As you may be aware, some business combinations with special purpose acquisition companies (SPACs) have not gone well. But one exception — at least so far — is eFFECTOR Therapeutics (NASDAQ:EFTR) and EFTR stock. Source: Shutterstock This clinical-stage biotechnology firm focuses on selective translation regulation inhibitors (STRIs) in cancer. EFTR stock is currently up some
0 Comments
Electric carmaker Tesla, Inc. (TSLA) is on a charm offensive in China. Elon Musk, the company’s CEO, recently lauded Chinese electric car makers, calling them “the most competitive in the world.” He has also committed to increasing investments toward the manufacturing and research of electric cars in the country. His company has promised to build
0 Comments